The Covid-19 pandemic creates an extra layer of concern for oncology patients who are just starting, in the midst of, or wrapping up treatment. Early reports raised concern when they indicated that Covid-19 mortality rates … Psoriasis: Myth Vs. Fact Description: Learn some facts about this skin disease and dispel myths associated with it. Back Skyrizi’s Rise Description: Learn more about Skyrizi™, the latest FDA-approved treatment for moderate-to-severe psoriasis. Back

With November being Healthy Skin Month, it’s the perfect time to give some extra attention to issues facing those with psoriasis. There are nearly 7.5 million Americans living with the dry, scaly, painful patches of skin typical of psoriasis. The most likely areas affected by psoriasis include skin around joints, face, neck, trunk, arms, hands, […]

The U.S. Food and Drug Administration approved a new treatment option for psoriasis patients earlier this year: AbbVie’s Skyrizi (risankizumab-rzaa). This medication, which is used as a subcutaneous injection, gained this approval after a series of studies showed a high rate of skin clearance in adults with severe plaque psoriasis using Skyrizi. Ready for even […]

August is National Psoriasis Awareness Month, making it the perfect time to share information about this skin disease and dispel myths associated with it. All in all, there’s a lot that your average patient might be misunderstanding about psoriasis. Click here to get the medications your psoriasis patients need today! Myth #1: That skin rash […]

Scroll to Top